Madorra Enrolls First Patient in Pivotal Trial for Treatment of Moderate to Severe Vulvovaginal Atrophy: The WAVES Study
Breakthrough Device-Designated Therapy System Takes Important Step Toward Market Authorization PORTLAND, OR, UNITED STATES, March 24, 2026 /EINPresswire.com/ — Madorra Inc., a medical device company developing innovative solutions for menopause-related conditions, today announced the enrollment of the first patient in... Read More →
A method of comprehensive sequencing analysis of the small RNA fragmentome (RiboMarker) featuring RealSeq Biosciences
Abstract Circulating cell-free nucleic acids (cfDNA and cfRNA) found in blood and other biofluids are promising biomarkers for cancer. However, current methods exploiting tumor-derived cfDNA (ctDNA) are not sensitive enough in detecting minimal residual disease and early stages of cancer... Read More →
CNN Exclusive: The futuristic foam that stops deadly internal bleeding
CNN spoke with the first person in the world to be treated with this futuristic material, called Res-Q-Foam, after he was seriously injured in a car crash last year and had just moments to live. Watch
Anumana Secures FDA Clearance for First-of-Its-Kind ECG-AI Algorithm for Early Detection of Pulmonary Hypertension
CAMBRIDGE, Mass. – March 28, 2026 – Anumana, a leader in cardiovascular AI, has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its pulmonary hypertension (PH) algorithm, an AI-enabled software-as-a-medical-device (SaMD) that detects early signs of PH, a... Read More →
How Genalyte Is Turning Same-Visit Diagnostics Into Lifesaving Decisions
Patient Stories: How MedTech Innovator alumni are transforming lives At MedTech Innovator we empower healthtech companies to bring groundbreaking solutions to patients in need. Our Patient Stories series highlights the real-world clinical impact of the companies we support—showcasing how their... Read More →
Starlight Cardiovascular Announces First Baby in the World Treated with Lifeline Stent System at Cincinnati Children’s Hospital
SAN DIEGO, March 24, 2026 /PRNewswire/ — Starlight Cardiovascular announced that the first baby in the world was treated with its Lifeline™ Ductus Arteriosus Stent System at Cincinnati Children’s Hospital in January. The device is currently being studied under a... Read More →
Xenocor Appoints David McNally as Chief Executive Officer, Antony Watson to Chief Commercial Officer and David Van Ness to Chief Technology Officer
Medical device industry veteran to lead expansion of Saberscope™, the market’s first and only single-use video platform for minimally invasive surgery, laparoscopic procedures, and advanced surgical visualization technologies. Xenocor announces David McNally as CEO and leadership appointments as the company... Read More →
AI-Enhanced ECG flags aortic stenosis years before symptoms featuring AccurKardia
Matthew Segar, MD, of The Texas Heart Institute, discusses new research evaluating whether AI‑enabled ECG analysis can detect aortic stenosis years before traditional symptom‑driven diagnosis. Because echocardiography is effective but not scalable for population screening, his team applied the previously... Read More →
Toro Neurovascular Announces FDA 510(k) Clearance for Toro 88 Superbore Catheter
First clinical cases successfully completed; U.S. launch to be led by Kaneka’s Neurovascular division IRVINE, Calif., March 11, 2026 (GLOBE NEWSWIRE) — Toro Neurovascular today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the... Read More →
Vitestro Raises $70 Million in Oversubscribed Series B Financing to Advance Autonomous Robotic Phlebotomy and Commercial Readiness
Labcorp Venture Fund, Mayo Clinic, Sutter Health, InterVest, MGFO, PGGM, Puma Venture Capital, and ROM Utrecht invest alongside existing investors Invest-NL, EIC Fund, Fred Moll, NYBC Ventures, and Sonder Capital. Utrecht, The Netherlands, March 10, 2026 – Vitestro, the pioneer... Read More →